Matthew Mishan
Stock Analyst at Keybanc
(2.44)
# 1,450
Out of 4,497 analysts
112
Total ratings
46.23%
Success rate
-1.16%
Average return
Main Sectors:
21 Stocks
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
RMD ResMed | Maintains: Overweight | $280 → $260 | $203.15 | +27.98% | 4 | Aug 4, 2023 | |
SHC Sotera Health Company | Maintains: Overweight | $24 → $23 | $13.09 | +75.71% | 7 | Aug 4, 2023 | |
STE STERIS | Maintains: Overweight | $254 → $258 | $224.29 | +15.03% | 12 | Aug 3, 2023 | |
BAX Baxter International | Maintains: Overweight | $53 → $51 | $35.35 | +44.27% | 10 | Jul 31, 2023 | |
ITGR Integer Holdings | Maintains: Overweight | $96 → $105 | $126.11 | -16.74% | 13 | Jul 28, 2023 | |
AXNX Axonics | Maintains: Overweight | $70 → $71 | $67.72 | +4.84% | 2 | Jul 28, 2023 | |
CNMD CONMED | Maintains: Overweight | $131 → $141 | $70.96 | +98.70% | 3 | Jul 27, 2023 | |
AVNS Avanos Medical | Downgrades: Sector Weight | n/a | $21.99 | - | 9 | Jul 25, 2023 | |
INSP Inspire Medical Systems | Maintains: Overweight | $321 → $335 | $143.74 | +133.06% | 4 | Jun 8, 2023 | |
ICUI ICU Medical | Maintains: Overweight | n/a | $122.30 | - | 10 | May 9, 2023 | |
PRCT PROCEPT BioRobotics | Maintains: Overweight | $48 → $47 | $67.47 | -30.34% | 3 | May 1, 2023 | |
BDX Becton, Dickinson and Company | Upgrades: Overweight | $304 | $230.74 | +31.75% | 4 | Apr 12, 2023 | |
SYK Stryker | Initiates: Sector Weight | n/a | $340.95 | - | 1 | Jan 25, 2023 | |
COO The Cooper Companies | Downgrades: Sector Weight | n/a | $90.75 | - | 19 | Aug 29, 2022 | |
ENOV Enovis | Downgrades: Sector Weight | n/a | $46.71 | - | 1 | Apr 21, 2022 | |
TFX Teleflex | Downgrades: Sector Weight | n/a | $221.79 | - | 4 | Oct 7, 2021 | |
INGN Inogen | Downgrades: Sector Weight | n/a | $9.25 | - | 1 | Aug 5, 2021 | |
LMAT LeMaitre Vascular | Initiates: Sector Weight | n/a | $86.20 | - | 1 | Feb 12, 2021 | |
ALC Alcon | Initiates: Sector Weight | n/a | $90.01 | - | 1 | Jul 6, 2020 | |
ANGO AngioDynamics | Downgrades: Sector Weight | n/a | $7.18 | - | 1 | Apr 8, 2020 | |
CTLT Catalent | Upgrades: Overweight | n/a | $57.91 | - | 2 | Mar 28, 2018 |
ResMed
Aug 4, 2023
Maintains: Overweight
Price Target: $280 → $260
Current: $203.15
Upside: +27.98%
Sotera Health Company
Aug 4, 2023
Maintains: Overweight
Price Target: $24 → $23
Current: $13.09
Upside: +75.71%
STERIS
Aug 3, 2023
Maintains: Overweight
Price Target: $254 → $258
Current: $224.29
Upside: +15.03%
Baxter International
Jul 31, 2023
Maintains: Overweight
Price Target: $53 → $51
Current: $35.35
Upside: +44.27%
Integer Holdings
Jul 28, 2023
Maintains: Overweight
Price Target: $96 → $105
Current: $126.11
Upside: -16.74%
Axonics
Jul 28, 2023
Maintains: Overweight
Price Target: $70 → $71
Current: $67.72
Upside: +4.84%
CONMED
Jul 27, 2023
Maintains: Overweight
Price Target: $131 → $141
Current: $70.96
Upside: +98.70%
Avanos Medical
Jul 25, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $21.99
Upside: -
Inspire Medical Systems
Jun 8, 2023
Maintains: Overweight
Price Target: $321 → $335
Current: $143.74
Upside: +133.06%
ICU Medical
May 9, 2023
Maintains: Overweight
Price Target: n/a
Current: $122.30
Upside: -
PROCEPT BioRobotics
May 1, 2023
Maintains: Overweight
Price Target: $48 → $47
Current: $67.47
Upside: -30.34%
Becton, Dickinson and Company
Apr 12, 2023
Upgrades: Overweight
Price Target: $304
Current: $230.74
Upside: +31.75%
Stryker
Jan 25, 2023
Initiates: Sector Weight
Price Target: n/a
Current: $340.95
Upside: -
The Cooper Companies
Aug 29, 2022
Downgrades: Sector Weight
Price Target: n/a
Current: $90.75
Upside: -
Enovis
Apr 21, 2022
Downgrades: Sector Weight
Price Target: n/a
Current: $46.71
Upside: -
Teleflex
Oct 7, 2021
Downgrades: Sector Weight
Price Target: n/a
Current: $221.79
Upside: -
Inogen
Aug 5, 2021
Downgrades: Sector Weight
Price Target: n/a
Current: $9.25
Upside: -
LeMaitre Vascular
Feb 12, 2021
Initiates: Sector Weight
Price Target: n/a
Current: $86.20
Upside: -
Alcon
Jul 6, 2020
Initiates: Sector Weight
Price Target: n/a
Current: $90.01
Upside: -
AngioDynamics
Apr 8, 2020
Downgrades: Sector Weight
Price Target: n/a
Current: $7.18
Upside: -
Catalent
Mar 28, 2018
Upgrades: Overweight
Price Target: n/a
Current: $57.91
Upside: -